| Gammaked, Gamunex-C |
125046 |
006 |
351(a) |
Immune Globulin Injection (Human) 10% Caprylate/Chromatography Purified |
Injection |
Intravenous |
40G |
Single-Use Bottle |
2003/08/27
|
Grifols Therapeutics LLC |
Rx |
Licensed |
|
N/A |
| Gammaked, Gamunex-C |
125046 |
007 |
351(a) |
Immune Globulin Injection (Human) 10% Caprylate/Chromatography Purified |
Injection |
Subcutaneous |
2.5G |
Single-Use Bottle |
2003/08/27
|
Grifols Therapeutics LLC |
Rx |
Licensed |
|
N/A |
| Gammaked, Gamunex-C |
125046 |
008 |
351(a) |
Immune Globulin Injection (Human) 10% Caprylate/Chromatography Purified |
Injection |
Subcutaneous |
5G |
Single-Use Bottle |
2003/08/27
|
Grifols Therapeutics LLC |
Rx |
Licensed |
|
N/A |
| Gammaked, Gamunex-C |
125046 |
009 |
351(a) |
Immune Globulin Injection (Human) 10% Caprylate/Chromatography Purified |
Injection |
Subcutaneous |
10G |
Single-Use Bottle |
2003/08/27
|
Grifols Therapeutics LLC |
Rx |
Licensed |
|
N/A |
| Gammaked, Gamunex-C |
125046 |
010 |
351(a) |
Immune Globulin Injection (Human) 10% Caprylate/Chromatography Purified |
Injection |
Subcutaneous |
20G |
Single-Use Bottle |
2003/08/27
|
Grifols Therapeutics LLC |
Rx |
Licensed |
|
N/A |
| Gammaked, Gamunex-C |
125046 |
011 |
351(a) |
Immune Globulin Injection (Human) 10% Caprylate/Chromatography Purified |
Injection |
Subcutaneous |
40G |
Single-Use Bottle |
2003/08/27
|
Grifols Therapeutics LLC |
Rx |
Licensed |
|
N/A |
| Advate |
125063 |
001 |
351(a) |
Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method |
For Injection |
Intravenous |
1500IU |
Single-Dose Vial |
2003/07/25
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Advate |
125063 |
002 |
351(a) |
Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method |
For Injection |
Intravenous |
500IU |
Single-Dose Vial |
2003/07/25
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Advate |
125063 |
003 |
351(a) |
Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method |
For Injection |
Intravenous |
250IU |
Single-Dose Vial |
2003/07/25
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Advate |
125063 |
004 |
351(a) |
Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method |
For Injection |
Intravenous |
1000IU |
Single-Dose Vial |
2003/07/25
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Ovidrel |
021149 |
002 |
351(a) |
choriogonadotropin alfa |
Injection |
Subcutaneous |
250MCG/0.5ML |
Pre-Filled Syringe |
2003/07/14
|
EMD Serono, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Zemaira |
125078 |
001 |
351(a) |
Alpha-1-Proteinase Inhibitor (Human) |
For Injection |
Intravenous |
1000MG |
Single-Dose Vial |
2003/07/08
|
CSL Behring LLC |
Rx |
Licensed |
|
N/A |
| Bexxar |
125011 |
001 |
351(a) |
tositumomab and iodine I-131 tositumomab |
Injection |
Intravenous |
35MG |
Single-Dose Vial |
2003/06/27
|
GlaxoSmithKline LLC |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Bexxar |
125011 |
002 |
351(a) |
tositumomab and iodine I-131 tositumomab |
Injection |
Intravenous |
225MG |
Single-Dose Vial |
2003/06/27
|
GlaxoSmithKline LLC |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Xolair |
103976 |
001 |
351(a) |
omalizumab |
For Injection |
Subcutaneous |
150MG |
Single-Dose Vial |
2003/06/20
|
Genentech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Flumist, Flumist Quad |
125020 |
001 |
351(a) |
Influenza Vaccine Live, Intranasal |
Suspension |
Nasal |
10X6.5-7.5 TCID |
Pump Spray |
2003/06/17
|
MedImmune, LLC |
Rx |
Licensed |
|
N/A |
| Human Albumin Grifols |
103352 |
002 |
351(a) |
Albumin (Human) |
Injection |
Intravenous |
20G/100ML |
Single-Dose Vial |
2003/06/11
|
Instituto Grifols, S.A. |
Rx |
Licensed |
|
N/A |
| Human Albumin Grifols |
103352 |
004 |
351(a) |
Albumin (Human) |
Injection |
Intravenous |
25G/100ML |
Single-Dose Vial |
2003/06/11
|
Instituto Grifols, S.A. |
Disc |
Licensed |
|
N/A |
| Avonex |
103628 |
002 |
351(a) |
interferon beta-1a |
Injection |
Intramuscular |
30MCG/0.5ML |
Pre-Filled Syringe |
2003/05/28
|
Biogen Inc. |
Rx |
Licensed |
N/A |
N/A |
| Monoclate, Monoclate-P |
103953 |
001 |
351(a) |
Antihemophilic Factor (Human) |
For Injection |
Intravenous |
500IU |
Vial |
2003/05/14
|
CSL Behring LLC |
Disc |
Voluntarily Revoked |
|
N/A |